Overview
Colon carcinoma refers to malignant tumors originating in the epithelial lining of the colon. Treatment often involves surgical resection, followed by adjuvant chemotherapy to reduce recurrence risk 1.Diagnosis
Imaging studies (CT, MRI) to assess tumor extent and metastasis 1.
Colonoscopy with biopsy for histopathological confirmation 1.
CEA (Carcinoembryonic Antigen) levels may correlate with disease progression 1.
Staging based on TNM classification to guide treatment decisions 1.Management
Surgery: Primary treatment, typically resection with lymph node assessment 1.
Adjuvant Chemotherapy: 5-fluorouracil (5-FU) often combined with oxaliplatin or capecitabine 1.
Pulmonary Toxicity Monitoring: Close surveillance for lomustine (CCNU)-induced pulmonary fibrosis, especially in long-term users 1.Special Populations
Comorbidities: Increased vigilance for pulmonary toxicity in patients receiving lomustine 1.Key Recommendations
Monitor patients closely for signs of pulmonary toxicity when lomustine is part of adjuvant therapy (Evidence: Weak) 1.
Consider alternative chemotherapy regimens if significant pulmonary comorbidities are present to avoid exacerbating respiratory issues (Evidence: Expert opinion) 1.
Utilize TNM staging to guide surgical and adjuvant treatment decisions (Evidence: Moderate) 1.References
1 Tucci E, Verdiani P, Di Carlo S, Sforza V. Lomustine (CCNU)-induced pulmonary fibrosis. Tumori 1986. link